Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01920477
Recruitment Status : Completed
First Posted : August 12, 2013
Last Update Posted : March 7, 2018
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 11, 2018
  Actual Study Completion Date : January 11, 2018